Patient Info

What is Constipation?

Below you will find a brief overview of constipation which covers the definition, incidence in the UK, types of constipation and lifestyle factors that can cause constipation. For a more in-depth review of constipation, please visit the NICE Clinical knowledge summary on constipation: http://cks.nice.org.uk/constipation

A normal bowel movement frequency is currently defined as occurring between three-times a day to once every three days. A patient is regarded as suffering from constipation if they have defecation that is unsatisfactory owing to infrequent stools, difficulty in passing stools or seemingly incomplete defaecation. Stools often appear dry, hard, and abnormally large or small.2,3

In the UK, 8% of the total population suffer from constipation.1 In England, this equated to 15.9 million prescriptions being dispensed for laxatives in 2010.3

Constipation is widespread in all ages; however, it is most likely to affect women, the elderly and women during pregnancy.3

Types of Constipation
There are two main types of constipation, functional constipation and organic constipation.

Functional Constipation
Functional constipation is chronic constipation without a known cause.3

Organic Constipation
Organic constipation is caused by a drug or underlying medical condition. Examples of drugs that can cause constipation include sedating antihistamines, antidepressants or antipsychotics. Examples of medical conditions that can cause constipation include diabetes mellitus, Parkinson’s disease, multiple sclerosis or irritable bowel syndrome.3

Risk Factors
There are many social and psychological factors that can increase the risk of constipation in adults, including a low fibre diet, lack of exercise/reduced motility, anxiety and depression.3

Constipation Resources
Please click the links below to leave the Aspire Pharma website and find out more information about constipation.








References: 1) Wald A, Kamm M, Mueller-Lissner S, Scarpignato C, Marx W, Schuijt C; An international survey of community prevalence of constipation and laxative use in adults. 2)www.patient.co.uk/doctor/constipation-in-adults 3) NICE Clinical Knowledge summary on Constipation (http://cks.nice.org.uk/constipation)

For further information, please call: 01730 231148, email: info@aspirepharma.co.uk
or visit www.aspirepharma.co.uk

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148
For more information about Lecicarbon A, please see full prescribing information.
Revision date ?? March 2015